CD4 and cytomegalovirus infection: A multi-center trial involving 23 patients with refractory CMV infection showed that 17 of these patients responded to VST infusion, although the authors of this study could not identify a correlation between CD4+ T cell numbers or percentage in the infused line with the strength of clinical response (Leen et al., 2013).